What are the currently accepted indications for BMD measurement?
• Age >65 years (women); age ≥70 (men).
• Estrogen deficiency plus one risk factor for osteoporosis.
• Vertebral deformity, fracture, or osteopenia by x-ray.
• Primary hyperparathyroidism.
• GC therapy, ≥5 mg/day of prednisone for ≥3 months.
• Monitoring the response to a Food and Drug Administration-approved osteoporosis medication.
